| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/03/2003 | US20030124557 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 07/03/2003 | US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 07/03/2003 | US20030124208 Alpha-amylase activity inhibitors |
| 07/03/2003 | US20030124207 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 07/03/2003 | US20030124196 Pulsatile release compositions and methods for enhanced intestinal drug absorption |
| 07/03/2003 | US20030124190 Methods and compositions for treating pain of the mucous membrane |
| 07/03/2003 | US20030124184 Liquiflash particles and an excipient mass; friability of less than 1%; need for conventional super disintegrant and having a friability of less than 1%; no need for conventional superdisintegrant |
| 07/03/2003 | US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix |
| 07/03/2003 | US20030124161 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
| 07/03/2003 | US20030124159 Enhancing epidermal barrier development in skin |
| 07/03/2003 | US20030124150 Kit for reducing aching |
| 07/03/2003 | US20030124136 Immunotherapy for reversing immune suppression |
| 07/03/2003 | US20030124132 Using targeted or non-targeted coagulants to cause tumor vasculature thrombosis. |
| 07/03/2003 | US20030124129 Angiopoietin-2 specific binding agents |
| 07/03/2003 | US20030124123 Also an IL-12 anti-idiotype antibody to the antibody |
| 07/03/2003 | US20030124114 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 07/03/2003 | US20030124113 Human apoptosis associated proteins |
| 07/03/2003 | US20030124111 Antimicrobial agent |
| 07/03/2003 | US20030124110 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 07/03/2003 | US20030124107 PAK5-related compositions and methods |
| 07/03/2003 | US20030124105 Programmed cell death genes and proteins |
| 07/03/2003 | US20030124100 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |
| 07/03/2003 | US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof |
| 07/03/2003 | US20030124075 Use of a composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
| 07/03/2003 | CA2486930A1 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | CA2471373A1 Modified tridegins, their preparation and their use as transglutaminase inhibitors |
| 07/03/2003 | CA2471355A1 Substituted diketopiperazines as oxytocin antagonists |
| 07/03/2003 | CA2471263A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/03/2003 | CA2471140A1 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | CA2471110A1 Peptides for treatment of the human papillomavirus(hpv)-associated cancer and other epithelial tumors |
| 07/03/2003 | CA2471107A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 07/03/2003 | CA2471098A1 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 07/03/2003 | CA2471089A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | CA2471085A1 Aroyl pyridinones |
| 07/03/2003 | CA2471083A1 Benzhydryl derivatives |
| 07/03/2003 | CA2471057A1 Benzothia(dia)zine derivatives and their use as ampa modulators |
| 07/03/2003 | CA2470999A1 Syn3 compositions and methods |
| 07/03/2003 | CA2470995A1 Methods of treating bacterial infections in dogs and cats |
| 07/03/2003 | CA2470964A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 07/03/2003 | CA2470938A1 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | CA2470931A1 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines |
| 07/03/2003 | CA2470844A1 Novel compositions and methods for cancer |
| 07/03/2003 | CA2470808A1 Piperazine derivative |
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | CA2470443A1 Pharmaceutical compositions based on azetidine derivatives |
| 07/03/2003 | CA2470148A1 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration |
| 07/03/2003 | CA2469904A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 07/03/2003 | CA2469894A1 Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 07/03/2003 | CA2469884A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 07/03/2003 | CA2469372A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production |
| 07/03/2003 | CA2469278A1 Isochroman compounds for treatment of cns disorders |
| 07/03/2003 | CA2469047A1 Tempamine compositions and methods of use |
| 07/03/2003 | CA2468627A1 Liposome composition for delivery of nucleic acid |
| 07/03/2003 | CA2468083A1 Use of heterocyclic carboxamides to treat anemia |
| 07/03/2003 | CA2466617A1 Food or pet food composition containing plant extract for bone health |
| 07/03/2003 | CA2462670A1 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | CA2453810A1 Mutant proteinase inhibitors and uses thereof |
| 07/03/2003 | CA2451993A1 Polypeptide, its conjugate with doxorubicin and conjugate-based pharmaceutical composition |
| 07/03/2003 | CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 07/03/2003 | CA2436850A1 Protease inhibitors |
| 07/02/2003 | EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions |
| 07/02/2003 | EP1323738A1 Negatively charged polysaccharide derivable form Aloe Vera |
| 07/02/2003 | EP1323735A1 Gene relating to drug tolerance and utilization thereof |
| 07/02/2003 | EP1323719A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
| 07/02/2003 | EP1323714A1 1,3-selenazole derivatives and their use as anticancer drugs or as agrochemicals |
| 07/02/2003 | EP1323712A1 Process for producing multiform crystal of donepezil hydrochloride |
| 07/02/2003 | EP1323711A1 Novel phenylalanine derivatives |
| 07/02/2003 | EP1323710A1 Nitrogenous five-membered ring compounds |
| 07/02/2003 | EP1323709A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 07/02/2003 | EP1323429A1 Preventives/remedies for emotional disorders |
| 07/02/2003 | EP1323423A1 Combined preparations comprising anthracycline derivatives |
| 07/02/2003 | EP1323420A1 Remedies for inflammatory bowel diseases |
| 07/02/2003 | EP1322954A1 Method for treatment of insulin resistance in obesity and diabetes |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/02/2003 | EP1322755A1 Human and mouse targeting peptides identified by phage display |
| 07/02/2003 | EP1322663A1 Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5- g(a)-androst-1-en-3-one and a process for preparing it |
| 07/02/2003 | EP1322652A1 Stereoselective process for preparing cyclohexyl amine derivatives |
| 07/02/2003 | EP1322651A1 Bicyclic heteroaromatic compounds |
| 07/02/2003 | EP1322650A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322644A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
| 07/02/2003 | EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 07/02/2003 | EP1322641A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 07/02/2003 | EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322635A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 07/02/2003 | EP1322634A1 N-phenyl-2-pyrimidine-amine derivatives |
| 07/02/2003 | EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai |
| 07/02/2003 | EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 07/02/2003 | EP1322622A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 07/02/2003 | EP1322621A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 07/02/2003 | EP1322620A1 Benzimidazole and indole derivatives as crf receptor modulators |
| 07/02/2003 | EP1322617A1 Compounds and methods for modulation of estrogen receptors |
| 07/02/2003 | EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 07/02/2003 | EP1322615A2 Fluorinated quinolones as antimitotic and antitumor agents |
| 07/02/2003 | EP1322611A1 Chemical compounds |
| 07/02/2003 | EP1322602A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds |